AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/08/2024 | Press release | Distributed by Public on 05/08/2024 14:41
Please select the service you want to use:
Smartlinks | Photocure ASA | News | Health | Finance | Security Markets | Security Markets | Company News | Corporate and Financial Calendar | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Stuttgart Stock Exchange | Euronext Oslo | OTC Markets | Nasdaq Stockholm | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Euronext Block MTF | Turquoise
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact